Cleared Traditional

K130749 - SYNGO.MR GENERAL

Also marketed or referenced as:
SYNGO.MR CARDIOLOGY SYNGO.MR VASCULAR

K130749 is an FDA 510(k) clearance for SYNGO.MR GENERAL, manufactured by Siemens Medical Solutions USA, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 154-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
154d
Days
Class 2
Risk

K130749 is an FDA 510(k) clearance for the SYNGO.MR GENERAL. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Siemens Medical Solutions USA, Inc. (Mavern, US). The FDA issued a Cleared decision on August 20, 2013 after a review of 154 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Siemens Medical Solutions USA, Inc. devices

FDA 510(k) Submission Details - K130749

510(k) Number K130749 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 2013
Decision Date August 20, 2013
Days to Decision 154 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d slower than avg
Panel avg: 107d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1793
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K130749.
MD242C2 24 DIAGNOSTIC IMAGING LCD MONITOR
K132587 · Ned Display Solutions , Ltd. · Aug 2013
CORVIEW
K131158 · Marrek, Inc. · Aug 2013
JUSHA-M32 MEDICAL DISPLAY
K131391 · Nanjing Jusha Display Technology Co., Ltd. · Aug 2013
LVIVO EF SYSTEM
K130779 · Diacardio, Ltd. · Aug 2013
ORTHOVISION
K131570 · Ewoosoft Co., Ltd. · Aug 2013
QLAB QUANTIFICATION SOFTWARE
K132165 · Philips Ultrasound, Inc. · Aug 2013